Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tucidinostat and Exemestane in ER+ Early Breast Cancer
NCT04465097Phase 2Completed
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Jul 2020
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tucidinostat in breast cancer, sponsored by The First Affiliated Hospital of Sun Yat-sen University. Started Jul 2020; status: completed.
02
Drugs
tucidinostat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04465097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04465097.